In vitro lymphocyte proliferation in response to phytohemagglutinin and streptokinase-streptodornase and delayed dermal hypersensitivity to several antigens were assessed in patients with mild viral upper respiratory infections. The response to phytohemagglutinin in 18 patients was not diminished during the viral infection. Deoxyribonucleic acid synthesis induced by streptokinasestreptodornase remained unaffected by the viral illness in five patients, and skin test reactivity was not depressed during the viral infection. Thus, it appeared that localized viral upper respiratory infections were not associated with suppression of systemic cell-mediated immunitv.
In vitro lymphocyte proliferation in response to phytohemagglutinin and streptokinase-streptodornase and delayed dermal hypersensitivity to several antigens were assessed in patients with mild viral upper respiratory infections. The response to phytohemagglutinin in 18 patients was not diminished during the viral infection. Deoxyribonucleic acid synthesis induced by streptokinasestreptodornase remained unaffected by the viral illness in five patients, and skin test reactivity was not depressed during the viral infection. Thus, it appeared that localized viral upper respiratory infections were not associated with suppression of systemic cell-mediated immunitv.
Cell-mediated immunity (CMI) in humans, measured by delayed dermal hypersensitivity or in vitro lymphocyte transformation, has been shown to be depressed during viral illnesses (10, 15, 18) and after vaccination against several viral diseases (8, 11) . However, few studies have examined whethex localized viral respiratory infections, which are rarely associated with viremia, produce a suppression of CMI. Influenza A infection has been shown to transiently decrease skin test reactivity (4, 12, 17) . Although some workers have demonstrated that influenza infection depresses the response of lymphocytes to phytohemagglutinin (PHA; 12), others have failed to document this effect (17) . Thomas (Table 2) . Lymphocytes taken from these five persons during the acute illness and again during convalescence responded normally to SK-SD (SI > 2.0). The four persons in these two groups with negative skin tests to SK-SD did not respond to this antigen during the illness or after convalescence (SI < 2.0).
Skin tests were performed on the men in group IV who received the rhinovirus challenge (Table 3) . There (8, 11, 15, 18) . This evidence has accumulated from the assessment of delayed dermal hypersensitivity (in vivo measure of CMI [6] ) and lymphocyte stimulation by antigens and mitogens (in vitro correlate of CMI [3] ). Measles virus has been most clearly shown to depress CMI (5, 8, 20) , but varicella, mumps, and rubella have also been implicated (1, 10, 11, 16) . All of these viral infections are characterized by viremia, systemic manifestations, and multi-organ involvement (7). Additionally, measles has been regularly associated with lymphopenia (9), and thymic atrophy has been found in some cases (22) .
In contrast, most uncomplicated viral respiratory infections are localized in the respiratory tract and do not lead to viremia (7). However, viremia has been documented during severe influenza (13, 14) , and with careful attention to cultural techniques Stanley and Jackson were able to show viremia during mild experimentally induced influenza infection (19) . Lymphopenia otf the extent seen in measles is uncommon in mild viral respiratory infections (9) .
Our data showed that mild viral upper respiratory infection did not cause a depression of lymphocyte response to PHA stimulation, and that SK-SD-induced lymphocyte proliferation Previous studies have documented a decrease in skin test reactivity during influenza (4, 12, 17) . Since only one person with mild influenza was skin-tested, no conclusions can be drawn about this parameter of CMI from our studv. but all persons infected with rhinovirus retained normal skin test reactivity during the illness.
These results are compatible with the concept that viral infections which are localized to the upper respiratory tract have little suppressive effect on systemic CMI, as measured by skin test reactivity to a variety of antigens and in vitro lymphocyte proliferation to PHA and SK-SD.
